Fulltext

Fighting Cancer around the World: A Framework for Action

Horgan D 1 , Mia R 2 , Erhabor T 3 , Hamdi Y 4 , Dandara C 5 , Lal JA 6 Show all authors , Fokom Domgue J 7 , Ewumi O 8 , Nyawira T 9 , Meyer S 10 , Kondji D 11 , Francisco NM 12 , Ikeda S 13 , Chuah C 14 , De Guzman R 15 , Paul A 16 , Reddy Nallamalla K 17 , Park WY 18 , Tripathi V 6 , Tripathi R 19 , Johns A 20 , Singh MP 21 , Phipps ME 22 , Dube F 23 , Whittaker K 24 , Mukherji D 25 , Rasheed HMA 26 , Kozaric M 1 , Pinto JA 27 , Doral Stefani S 28 , Augustovski F 29 , Aponte Rueda ME 30 , Fujita Alarcon R 31 , Barrera-Saldana HA 32

Affiliations 

  • 1 European Alliance for Personalised Medicine, 1040 Brussels, Belgium
  • 2 Genomics Centre, South African Medical Research Council, Tygerberg, Cape Town 7500, South Africa
  • 3 Medical Laboratory Science Council of Nigeria (MLSCN), Durumi, Abuja 900110, Nigeria
  • 4 Laboratory of Biomedical Genomics and Oncogenetics, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis 1002, Tunisia
  • 5 Division of Human Genetics, Department of Pathology, Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Observatory, Cape Town 7925, South Africa
  • 6 Department of Molecular and Cellular Engineering, Jacob Institute of Biotechnology and Bioengineering, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj 211007, India
  • 7 Departments of Epidemiology, and Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Centre, Houston, TX 77030, USA
  • 8 Freelance Health Care, Life Sciences, Medical Artificial Intelligence Content Writer, Lagos 100253, Nigeria
  • 9 National Commission for Science, Technology and Innovation in Kenya (NACOSTI), Nairobi 00100, Kenya
  • 10 Cancer Alliance, Cape Town 7700, South Africa
  • 11 Health & Development Communication, Building Capacities for Better Health in Africa, Yaounde P.O. Box 2032, Cameroon
  • 12 Grupo de Investigação Microbiana e Imunológica, Instituto Nacional de Investigação em Saúde (National Institute for Health Research), Luanda 3635, Angola
  • 13 Department of Precision Cancer Medicine, Tokyo Medical and Dental University, Tokyo 113-8510, Japan
  • 14 Singularity University, P.O. Box 165, Gold Coast, QLD 4227, Australia
  • 15 Oncology and Pain Management Section, Manila Central University-Filemon D. Tanchoco Medical Foundation Hospital, Caloocan 1400, Philippines
  • 16 Department of Mathematics and Statistics, Faculty of Science, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj 211007, India
  • 17 ACCESS Health India, Hyderabad 500086, India
  • 18 Samsung Genome Institute, Samsung Medical Centre, Sungkyunkwan University, Seoul 06351, Korea
  • 19 Ministry of Labor, Health Department Government of India, New Delhi 110001, India
  • 20 Garvan Institute of Medical Research and the Kinghorn Cancer Centre, Cancer Division, Sydney, NSW 2010, Australia
  • 21 Centre of Biotechnology, University of Allahabad, Allahabad 211002, India
  • 22 Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Subang Jaya 47500, Selangor, Malaysia
  • 23 Astra Zeneca, 1800 Concord Pike, Wilmington, DE 19803, USA
  • 24 Cancer Council Australia, Sydney, NSW 2000, Australia
  • 25 Global Health Institute, American University of Beirut, Beirut VFXP+7QF, Lebanon
  • 26 Qatar Cancer Society, Doha 22944, Qatar
  • 27 Centre for Basic and Translational Research, Auna Ideas, Lima 15036, Peru
  • 28 UNIMED RS, Porto Alegre 90040-180, Brazil
  • 29 Health Technology Assessment and Health Economics, Department of the Institute for Clinical Effectiveness and Health Policy (IECS-CONICET), Buenos Aires C1056ABH, Argentina
  • 30 Venezuelan Breast Cancer Research and Education Foundation, Caracas 1060, Venezuela
  • 31 Centro de Genética y Biología Molecular, Universidad de San Martín de Porres, Lima 15024, Peru
  • 32 Innbiogem SC/Vitagenesis SA at National Laboratory for Services of Research, Development, and Innovation for the Pharma and Biotech Industries (LANSEIDI) of CONACyT Vitaxentrum Group, Monterrey 64630, Mexico
Healthcare (Basel), 2022 Oct 25;10(11).
PMID: 36360466 DOI: 10.3390/healthcare10112125

Abstract

Tackling cancer is a major challenge right on the global level. Europe is only the tip of an iceberg of cancer around the world. Prosperous developed countries share the same problems besetting Europe-and the countries and regions with fewer resources and less propitious conditions are in many cases struggling often heroically against a growing tide of disease. This paper offers a view on these geographically wider, but essentially similar, challenges, and on the prospects for and barriers to better results in this ceaseless battle. A series of panels have been organized by the European Alliance for Personalised Medicine (EAPM) to identify different aspects of cancer care around the globe. There is significant diversity in key issues such as NGS, RWE, molecular diagnostics, and reimbursement in different regions. In all, it leads to disparities in access and diagnostics, patients' engagement, and efforts for a better understanding of cancer.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications